Latest From Biotech Now

Access to Big Data

Emerging-Companies115x76

Aquiring information rapidly and reliably reduces costs and advances discovery Sixty years ago, when James Watson and Francis Crick elucidated and published their seminal work on the double helical nature of DNA, they could hardly have imagined the explosion of information about cellular activities and disease pathways happening today. With this explosion, the challenge for scientific database producers is to curate and process the published literature, small molecules, proteins, sequences and numeric data in ways Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Industry-Disease Foundation Partnerships Thrive on Communication & Transparency

Attendees

Disease foundations are playing an increasingly important role in advancing research and helping to bring new treatments to market. Their unique expertise in specific disease areas, along with their keen understanding of patient needs and access to clinical thought leaders and patients, can enhance and accelerate the clinical development of new treatments. At a 2014 BIO International Convention Breakout Session, session moderator Gail Maderis, President and CEO of BayBio, opened with some key statistics about Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Turning Urban Waste into Bioplastic

lab_tech

Bacteria possible key to produce useful bioplastics from the gasification of urban waste Each year, the European Union produces three billion tonnes of waste. According to Eurostat (the statistical office of the European Union), this equates to six tonnes of solid waste for every EU citizen. A major challenge is finding ways to reduce and reuse a large amount of this waste. But now, the EU funded Synpol Project, which aims to propel the sustainable Read More >

Environmental & Industrial  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Why We Do This Work

rachel-king

In her keynote remarks delivered yesterday at the 2014 BIO International Convention, Rachel King, president & CEO of GlycoMimetics and chairperson of the board of the Biotechnology Industry Organization (BIO), talked about why entrepreneurs pursue opportunities in biotechnology and what sustains these industry leaders through the rollercoaster of raising money, clinical trials, road shows and all the ups and downs of bringing medical innovations from the lab to the bedside. “Working in biotechnology today, we Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Seeing is Believing

brain-scan

PET and MRI imaging helps companies to make go/no go decisions earlier Attrition or failure of new drug programs is a major source of concern, with failure rates ranging from 75 percent in anti-infectives to 92 percent in CNS according to DiMasi’s 2010 study (Clin. Pharmacol. Ther. 87, 272-277). Molecular imaging – both Positron Emission Tomography (PET) and Magnetic Resonance Imaging (MRI) can help improve these dismal statistics. Given the immense costs involved in the Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,